OBJECTIVE: To develop and validate a questionnaire for supraesophageal manifestations of reflux (SER) that will facilitate its study in clinical and research settings. STUDY DESIGN: The Supraesophageal Reflux Questionnaire (SERQ) and previously validated Reflux Symptom Index (RSI) were subjected to multiple types of validity testing, including content validity, concurrent validity, reproducibility, and predictive validity. RESULTS: The concurrent validity and reproducibility of both instruments was good to excellent for most items tested. The predictive validity of the SERQ was superior to the RSI when it included the covariates of history of sinusitis, use of over-the-counter antacid medications, age, gender, and body mass index. CONCLUSIONS: The SERQ will serve as both a useful clinical and research tool by offering not only SER symptom information, like the RSI, but also information about the patient's medical history and medication usage that will facilitate use of the SERQ in research protocols. EBM RATING: B-2b.
OBJECTIVE: To develop and validate a questionnaire for supraesophageal manifestations of reflux (SER) that will facilitate its study in clinical and research settings. STUDY DESIGN: The Supraesophageal Reflux Questionnaire (SERQ) and previously validated Reflux Symptom Index (RSI) were subjected to multiple types of validity testing, including content validity, concurrent validity, reproducibility, and predictive validity. RESULTS: The concurrent validity and reproducibility of both instruments was good to excellent for most items tested. The predictive validity of the SERQ was superior to the RSI when it included the covariates of history of sinusitis, use of over-the-counter antacid medications, age, gender, and body mass index. CONCLUSIONS: The SERQ will serve as both a useful clinical and research tool by offering not only SER symptom information, like the RSI, but also information about the patient's medical history and medication usage that will facilitate use of the SERQ in research protocols. EBM RATING: B-2b.
Authors: David O Francis; Dhyanesh A Patel; Rohit Sharda; Kristen Hovis; Nila Sathe; David F Penson; Irene D Feurer; Melissa L McPheeters; Michael F Vaezi Journal: Otolaryngol Head Neck Surg Date: 2016-08-23 Impact factor: 3.497
Authors: Judith McElhiney; Matthew R Lohse; Amindra S Arora; Joanna M Peloquin; Debra M Geno; Melissa M Kuntz; Felicity B Enders; Mary Fredericksen; Adil A Abdalla; Yulia Khan; Nicholas J Talley; Nancy N Diehl; Timothy J Beebe; Ann M Harris; Gianrico Farrugia; Darlene E Graner; Joseph A Murray; G Richard Locke; Rayna M Grothe; Michael D Crowell; Dawn L Francis; April M B Grudell; Tushar Dabade; Angelica Ramirez; MhdMaan Alkhatib; Jeffrey A Alexander; Jessica Kimber; Ganapathy Prasad; Alan R Zinsmeister; Yvonne Romero Journal: Dysphagia Date: 2009-10-24 Impact factor: 3.438
Authors: Shawn D Aaron; Katherine L Vandemheen; Louis-Philippe Boulet; R Andrew McIvor; J Mark Fitzgerald; Paul Hernandez; Catherine Lemiere; Sat Sharma; Stephen K Field; Gonzalo G Alvarez; Robert E Dales; Steve Doucette; Dean Fergusson Journal: CMAJ Date: 2008-11-18 Impact factor: 8.262
Authors: E Y Chang; R C Minjarez; C Y Kim; A K Seltman; D V Gopal; B Diggs; R Davila; J G Hunter; B A Jobe Journal: Surg Endosc Date: 2007-03-08 Impact factor: 4.584